- Bladder cancer 2024
- Overactive bladder syndrome
- Duplex Congenital Malformations of the UT
- Bipolar enucleation of the prostate
- Duplex Congenital Malformations of the UT
- Nocturia QR Code
- Fatigue in prostate cancer patients – HCP Guide
- What is cancer?
- Kidney stones plus QR Code
- Erectile dysfunction
- BPE QR Code
- ADT-related CVD QR Code
- PSA Testing QR Code
- Orchidectomy QR Code
- Hormone therapy QR Code
- Prostate Cancer QR Code
- Urinary Infections QR Code
- Urinary Incontinence QR Code
- CPP Sept 2022
- Chronic Pelvic Pain (CPP)
- Urinary Infections
- Overactive Bladder 2022
- Cancer at Work – Tips for employers supporting employees with cancer
- Cancer at Work – Tips for employees diagnosed with cancer
- Flyer ADT Online Educational Class
- EAU21 Patient Poster Session – Key messages
- Roundtable Discussion EAU21
- ECL Rehabilitation Atlas 2021
- Chronic Pelvic Pain Syndrome
- Hormone Therapy
- EAU21 Patient Poster Session – What have we learned
- EAU22 Rules for abstract submission PI
- IKCC Report: The impact of COVID-19 on the kidney cancer community
- Orchidectomy
- EAU21 Roundtable – The Road to Succesful Intervention – Patient Information session
- EAU21 Patient Poster presentations – Patient Information session Friday 9 July 2021
- EAU21 Kidney cancer Patient Information session – 9 July 2021
- EAU21 Functional Urology Patient Information session – 9 July 2021
- Prostate Cancer
- Hormone Therapy and the Risk of Cardiovascular Disease in Patients with Prostate Cancer
- Early Detection HVP – Hogenhout et al. 2020
- Study Non-metastatic Castration-Resistant Prostate
- Patient Summary Darolutamide and survival in nonmetastatic castration-resistant prostate cancer – A Patient perspective of the ARAMIS trial
- EAU21 Treatment sequencing in metastatic prostate cancer
- EAU21 Treatment for metastatic hormone-sensitive prostate cancer
- EAU21 Metastatic prostate cancer: Systemic treatments and options of loc treatment in oligometastatic disease
- EAU21 Metastatic prostate cancer – Poster Session 29
- EAU21 Guideline Session II: Prostate cancer – cN+ in newly diagnosed patients
- EAU21 Game changing session 5
- EAU21 Urinary biomarkers: Are we there yet?
- EAU21 Telemedicine in urology
- EAU21 Ready for take-off: Molecular markers for clin management of urological malignancies
- EAU21 History of urology at a glance
- EAU21 Germline genetic testing and clin cons for patients and relative in onco-urology
- EAU21 Controversies in onco-urology
- EAU21 Clinical trials Poster Session 30
- EAU21 Best of EAU21 poster abstracts
- EAU21 Immunotherapy in urothelial cancer
- EAU21 Renal tumours – Locally advanced and metastatic disease
- EAU21 Nephron-sparing treatment in localised kidney cancer
- EAU21 Localised renal tumour diagnosis and prognosis in the digitalised era
- EAU21 A tale of three kidneys – Complex and salvage robotic kidney surgery
- EAU21 Prostate Cancer PI Session
- World Continence Week 2021 – WFIPP Webinar Programme
- EAU21 Functional Urology PI Session
- EAU21 Life After Cancer Treatment PI Session
- EAU21 PIONEER prostate cancer platform
- EAU21 How machine learning is transforming diagnostics
- EAU21 Guidelines Poster Session 11
- EAU21 Controversies in Bladder Cancer 2021: Rapid-fire debates
- EAU21 Advanced bladder cancer in 2021: Going forward?
- EAU21 Kidney cancer – Patient Information Session
- EAU21 Bladder cancer – Patient Information Session
- Prostate Cancer Patient Guide (Prostate Cancer Foundation)
- EAU21 Plenary session 04 – Renal cancer: from localised to metastatic disease
- EAU21 Poster Session 19 – Liquid biopsies, biomarkers and novel therapies in renal tumours
- EAU21 Poster Session 07 – Patient engagement
- EAU21 Roundtable The Road to successful interventions
- EAU21 Patient poster presentations
- Cost and value of surgery for kidney cancer patients in the USA
- Joint Letter on COVID-19 and Cancer
- EU Beating Cancer Plan
- EAU Guidelines on Renal Cell Carcinoma
- MAC Guide PCa
- How to manage cancer at work – ECL Cancer at Work Handbook
- EMA medical terms simplifier
- ECPC personalised medicine booklet
- Patient Summary BCa Newsletter March 2021
- Study Mentall Illness and Bladder Cancer Patients
- Patient Summary GO BCa Newsletter March 2021
- Patient Summary PCa Newsletter February 2021
- Full text Living with Prostate Cancer and ADT
- ADT-programme endorsement by Mrs. Louise Fleure
- Patient Summary GO RCC Newsletter January 2021
- Full text EAU Guidelines Update on RCC – Nivolumab plus Cabozantinib
- Patient Summary RCC Newsletter January 2021
- Full text Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer
- Full text Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
- Patient Summary BCa Newsletter December 2020
- Patient Summary PCa Newsletter November 2020
